Skip to main content

Claybrook Capital, LLC

SEC CIK
0001729848
Latest filing
Oct 24, 2023

PFE holding history

Pfizer Inc in every 13F filed by Claybrook Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PFE overviewAll 13F holders of PFEFull Q3 2023 holdings

Shares (Q3 2023)
10,705
Value
$355.1K
% of portfolio
0.2%
Quarters held
11
Since Q1 2021
Holdings of PFE by Claybrook Capital, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 202310,705$355.1K0.2%+205+2.0%AddedHolders
Q2 202310,500$385.1K0.2%00.0%UnchangedHolders
Q1 202310,500$428.4K0.2%00.0%UnchangedHolders
Q4 202210,500$538.0K0.3%−4,135−28.3%ReducedHolders
Q3 202214,635$640.0K0.4%00.0%UnchangedHolders
Q2 202214,635$767.0K0.5%−50−0.3%ReducedHolders
Q1 202214,685$760.0K0.4%−75−0.5%ReducedHolders
Q4 202114,760$872.0K0.4%+75+0.5%AddedHolders
Q3 202114,685$632.0K0.3%−83,961−85.1%ReducedHolders
Q2 202198,646$3.86M1.3%+52,961+115.9%AddedHolders
Q1 202145,685$1.66M1.0%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.